Stem Cells Translational Medicine News
June 2013 — Martin Stratmann, Ph.D., has been appointed the new president of the Max Planck Society. He is scheduled to take office in June 2014.
June 2013 — Mammals possess the remarkable ability to regenerate a lost fingertip, including the nail, nerves and even bone. In humans, an amputated fingertip can sprout back in as little as two months, a phenomenon that has remained poorly understood until now.
June 2013 — Stem cell researchers in Europe have gained ground in their challenge to a ban on embryonic patents after a High Court judge in London referred a question back to the European Court of Justice as to whether the ban should include all types of embryonic stem cells.
June 2013 — Transferring four genes into mouse cells enabled researchers at the Icahn School of Medicine at Mount Sinai to produce cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day.
June 2013 - The U.S. Food and Drug Administration (FDA) has placed a clinical hold on a trial being conducted by Pluristem Therapeutics Inc. after one of the patients suffered a serious allergic reaction. Pluristem, a developer of placenta-based cell therapies based in Haifa, Israel, is conducting a phase II study of its investigational treatment for calf pain symptoms.
June 2013 — Scientists at the University of Copenhagen’s Danish Stem Cell Center (DanStem) have learned how to make embryonic stem cells regress to a stage of development where they can form any kind of cell. The discovery has the potential to shed new light on placenta-related disorders that can lead to problematic pregnancies and miscarriages.
May 2013 — Scientists have discovered that Type 1 diabetes destroys not only insulin-producing cells but also blood vessels that support them. The revelation is leading to a potential cure that combines adult stem cells with a promising new drug.
May 2013 — Five patients who were seriously disabled by stroke are showing signs of recovery after being treated with stem cells.
The patients were part of a small Phase I clinical trial testing the safety and effectiveness of stem cell treatments for stroke. It involves nine patients ranging in age from their 60s to their 80s and is being conducted at Glasgow's Southern General Hospital in Scotland.
- ‘Alligator smile’ could offer clues to regenerating human teeth
- Agency awards $42 million-plus for stem cell research and leadership funding
- Errors found in groundbreaking human stem cell cloning study
- Researchers convert human skin cells into embryonic stem cells
- Study sheds new light on how stem cells help repair injuries to brain and spinal cord
- Stem cell-engineered artificial trachea gives toddler new lease on life
- Discovery of age-reversing protein could lead to effective heart failure treatment
- Stem cell researchers move toward treatment for rare nerve disease
- Bioengineered Rat Kidney Produces Urine
- Novel surface marker helps ‘fish out’ mammary gland stem cells